Objectives
•Establish relevance of JAK1 and JAK2 inhibition in dermatology
•Review the latest clinical trial and RWE data of Baricitinib in AD and AA
•Exchange the real-world clinical experiences and learnings of Baricitinib in AD and AA
This Course For :
Physician
( Dermatology , Family Medicine , Internal Medicine )
Resident / Fellow
( Dermatology , Family Medicine , Internal Medicine )
Speaker
.png "Dr.Ignasi Figueras-Nart")
Dr.Ignasi Figueras-Nart
• Academic faculty at the University of Barcelona, Spain
• Dermatologist at the Department of Dermatology, Hospital Universitaride Bellvitge, Spain
.png "Prof.Jacob Thyssen")
Prof.Jacob Thyssen
• Academic faculty at the University of Copenhagen, Denmark
• Consultant dermatologist at Herlev-Gentofte Hospital, Denmark
• Member of the International Eczema Council (IEC), the European Task Force of Atopic Dermatitis (ETFAD), the European Society of Contact Dermatitis (ESCD), and the European Dermato-Epidemiology Network (EDEN)
• Received the Fischer Gold Award in 2012 from the American Contact Dermatitis Society
.png "Prof.Andreas Wollenberg")
Prof.Andreas Wollenberg
•Professor in the Department of Dermatology and Allergy, Ludwig-Maximilian University of Munich, Germany
•Member of the American Academy of Allergy Asthma and Immunology (AAAAI), the Collegium Internationale Allergologicum(CIA) and the European Dermatology Forum (EDF)
•Chair of the Eczema/Atopic Dermatitis Task Force of the European Academy of Dermatology and Venerology(EADV) and an executive board member of the International Society of Atopic Dermatitis (ISAD)
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Note : This content is approved by Eli Lilly and company (“Lilly”). This content is intellectual property of Lilly and its reproduction needs Lilly's prior permission
Free
15 Feb 2023 To 15 Feb 2023 -
10:00 PM To 11:00 PM 
Certificate Available 
Online Click Here
- 310
Add to Calendar
02/15/2023 10:00 PM
02/15/2023 11:00 PM
Asia/ Riyadh
Exploring Oral JAK Inhibition in Dermatology - Building on the Experience with Baricitinib
Exploring Oral JAK Inhibition in Dermatology - Building on the Experience with Baricitinib
https://medicalacademy.org/portal/event/view/1902
